Interleukin 1 receptor-associated kinase m impairs host defense during pneumococcal pneumonia.
暂无分享,去创建一个
T. van der Poll | R. Flavell | G. V. D. van der Windt | Koichi S. Kobayashi | A. D. de Vos | S. Florquin | C. van’t Veer | D. Blok | J. Hoogerwerf | A. Lammers
[1] T. van der Poll,et al. Osteopontin impairs host defense during pneumococcal pneumonia. , 2011, The Journal of infectious diseases.
[2] T. van der Poll,et al. Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia , 2010, European Respiratory Journal.
[3] Steven L. Kunkel,et al. Critical Role of IL-1 Receptor-Associated Kinase-M in Regulating Chemokine-Dependent Deleterious Inflammation in Murine Influenza Pneumonia , 2009, The Journal of Immunology.
[4] S. Opal,et al. Pathogenesis, treatment, and prevention of pneumococcal pneumonia , 2009, The Lancet.
[5] S. Biswas,et al. Endotoxin tolerance: new mechanisms, molecules and clinical significance. , 2009, Trends in immunology.
[6] A. D. de Vos,et al. TREM-1 Activation Alters the Dynamics of Pulmonary IRAK-M Expression In Vivo and Improves Host Defense during Pneumococcal Pneumonia1 , 2009, The Journal of Immunology.
[7] C. Tsatsanis,et al. Adiponectin Promotes Endotoxin Tolerance in Macrophages by Inducing IRAK-M Expression1 , 2009, The Journal of Immunology.
[8] C. Dinarello,et al. Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.
[9] Ping Wang,et al. A novel method to determine the engulfment of apoptotic cells by macrophages using pHrodo succinimidyl ester. , 2009, Journal of immunological methods.
[10] B. Beutler. TLRs and innate immunity. , 2009, Blood.
[11] T. van der Poll,et al. Immunosuppression associated with interleukin-1R-associated-kinase-M upregulation predicts mortality in Gram-negative sepsis (melioidosis) , 2009, Critical care medicine.
[12] T. van der Poll,et al. Stimulation of acetylcholine receptors impairs host defence during pneumococcal pneumonia , 2008, European Respiratory Journal.
[13] F. Hassan,et al. Involvement of interleukin-1 receptor-associated kinase (IRAK)-M in toll-like receptor (TLR) 7-mediated tolerance in RAW 264.7 macrophage-like cells. , 2009, Cellular immunology.
[14] Xian-feng Chen,et al. Up-regulation of IRAK-M is essential for endotoxin tolerance induced by a low dose of lipopolysaccharide in Kupffer cells. , 2008, The Journal of surgical research.
[15] Y. Iwakura,et al. Contribution of IL-1 to resistance to Streptococcus pneumoniae infection. , 2008, International immunology.
[16] C. Coban,et al. Host innate immune receptors and beyond: making sense of microbial infections. , 2008, Cell host & microbe.
[17] T. van der Poll,et al. Host-pathogen interactions in sepsis. , 2008, The Lancet. Infectious diseases.
[18] T. van der Poll,et al. Induction of IRAK-M Is Associated with Lipopolysaccharide Tolerance in a Human Endotoxemia Model , 2007, The Journal of Immunology.
[19] M. Bergeron,et al. Differential Contribution of Bacterial N-Formyl-Methionyl-Leucyl- Phenylalanine and Host-Derived CXC Chemokines to Neutrophil Infiltration into Pulmonary Alveoli during Murine Pneumococcal Pneumonia , 2007, Infection and Immunity.
[20] Liwu Li,et al. Loss of the innate immunity negative regulator IRAK-M leads to enhanced host immune defense against tumor growth. , 2007, Molecular immunology.
[21] T. van der Poll,et al. CD14 facilitates invasive respiratory tract infection by Streptococcus pneumoniae. , 2007, American journal of respiratory and critical care medicine.
[22] S. Akira,et al. Toll‐like receptor 9 acts at an early stage in host defence against pneumococcal infection , 2007, Cellular microbiology.
[23] J. Bartlett,et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults , 2007, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[24] C. Snapper,et al. TLR2 synergizes with both TLR4 and TLR9 for induction of the MyD88-dependent splenic cytokine and chemokine response to Streptococcus pneumoniae. , 2007, Cellular immunology.
[25] T. van der Poll,et al. Oxidized Phospholipids Inhibit Phagocytosis and Impair Outcome in Gram-Negative Sepsis In Vivo1 , 2007, The Journal of Immunology.
[26] T. Standiford,et al. Sepsis-induced suppression of lung innate immunity is mediated by IRAK-M. , 2006, The Journal of clinical investigation.
[27] T. Mitchell,et al. Innate immunity and the pneumococcus. , 2006, Microbiology.
[28] M. Hornef,et al. Myeloid differentiation factor 88‐dependent signalling controls bacterial growth during colonization and systemic pneumococcal disease in mice , 2005, Cellular microbiology.
[29] F. Liew,et al. Negative regulation of Toll-like receptor-mediated immune responses , 2005, Nature Reviews Immunology.
[30] S. Akira,et al. Toll-Like Receptor 2 Plays a Role in the Early Inflammatory Response to Murine Pneumococcal Pneumonia but Does Not Contribute to Antibacterial Defense1 , 2004, The Journal of Immunology.
[31] T. van der Poll,et al. Thrombomodulin mutant mice with a strongly reduced capacity to generate activated protein C have an unaltered pulmonary immune response to respiratory pathogens and lipopolysaccharide. , 2004, Blood.
[32] S. Okugawa,et al. Involvement of IRAK-M in Peptidoglycan-induced Tolerance in Macrophages* , 2004, Journal of Biological Chemistry.
[33] T. van der Poll,et al. Role ofToll-Like Receptor 4 in Gram-Positive and Gram-Negative Pneumonia inMice , 2004, Infection and Immunity.
[34] M. Lipsitch,et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[35] R. Hotchkiss,et al. The pathophysiology and treatment of sepsis. , 2003, The New England journal of medicine.
[36] S. Akira,et al. IL-18 Improves the Early Antimicrobial Host Response to Pneumococcal Pneumonia , 2002, The Journal of Immunology.
[37] T. van der Poll,et al. TNF-α Compensates for the Impaired Host Defense of IL-1 Type I Receptor-Deficient Mice During Pneumococcal Pneumonia1 , 2001, The Journal of Immunology.
[38] M. Bergeron,et al. Microbiological and inflammatory factors associated with the development of pneumococcal pneumonia. , 2001, The Journal of infectious diseases.
[39] H. Volk,et al. Clinical aspects: from systemic inflammation to 'immunoparalysis'. , 2000, Chemical immunology.
[40] G. Stark,et al. IRAK-M Is a Novel Member of the Pelle/Interleukin-1 Receptor-associated Kinase (IRAK) Family* , 1999, The Journal of Biological Chemistry.
[41] J. Bernstein. Treatment of Community-Acquired Pneumonia— IDSA Guidelines , 1999 .
[42] F. Schildberg,et al. Downregulation of proinflammatory cytokine release in whole blood from septic patients. , 1995, Blood.
[43] C. S. Park,et al. A rapid and simple microfluorometric phagocytosis assay. , 1993, Journal of immunological methods.
[44] C. McCall,et al. Tolerance to endotoxin-induced expression of the interleukin-1 beta gene in blood neutrophils of humans with the sepsis syndrome. , 1993, The Journal of clinical investigation.
[45] J. Cavaillon,et al. Dysregulation of in vitro cytokine production by monocytes during sepsis. , 1991, The Journal of clinical investigation.
[46] J. Enders,et al. Infectious Diseases Society of America. , 1969, Antimicrobial agents and chemotherapy.